Abbott Laboratories: Q4 Earnings On The Horizon

Core Viewpoint - Abbott Laboratories (ABT) was trading at approximately $118 per share in late 2024, and the stock was rated a HOLD due to its small premium without offering significant value [1]. Company Analysis - The stock price of Abbott Laboratories was noted to be around $118 per share when the analysis was conducted [1]. - The analysis indicates that the stock was perceived to be trading at a small premium, suggesting limited upside potential at that time [1]. Analyst Background - The analyst has over 10 years of experience in the investment arena, starting as an analyst and progressing to a management role [1]. - The analyst holds a master's degree in Analytics and a bachelor's degree in Accounting, indicating a strong educational background relevant to financial analysis [1].